Is Avocado Lipid Profile Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Avocado Lipid Profile Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - The HAT was a multicenter trial with 4 clinical centers and a coordinating center designed to evaluate the effect of consuming 1 avocado per day on visceral adiposity (primary endpoint) and other cardiometabolic risk factors (secondary endpoints) in 1008 participants [,]. [Kris-Etherton Penny M (2026); evidence level 4] - Effects of avocado consumption on diet quality  Penn State 5 Examine changes in the HEI-2015 after a food-based intervention and assess the associations between HEI-2015 change and intervention effects on cardiometabolic risk–related outcomes []. [Kris-Etherton Penny M (2026); evidence level 4] - Daily consumption of 1 avocado within the AD significantly reduced glycemic load, but not glycemic index, without requiring significant dietary changes. [Kris-Etherton Penny M (2026); evidence level 4] - Many clinical trials examining the health effects of single foods have been conducted, and the findings have informed recommendations for healthy eating/dietary patterns. [Kris-Etherton Penny M (2026); evidence level 4] - Background Avocado consumption has been associated with improvements in diet quality and cardiometabolic risk factors, but effects on serum metabolite profiles remain underexplored. [Matthan NR (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.